Form 4: DarioHealth Director Receives Stock Grant
Insider Transaction (Form 4)
Yoav Shaked, a Director of DarioHealth Corp., reported multiple transactions in common stock on August 12, 2024.
Summary
- Conversion of derivative: acquired 772 Common Stock at $19.10 ($14,745) on August 12, 2024; holds 33,582 after (Direct).
- Grant/award: acquired 54,000 Common Stock on September 24, 2026; holds 87,582 after (Direct).
- Conversion of derivative: disposed of 40 Series B-2 Preferred Stock at $1,000.00 ($40,000) on August 12, 2024 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Yoav Shaked — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2024-08-12 | Conversion of derivative | Common Stock | 772 | $19 | $14.7K | 33,582 |
| 2026-09-24 | Grant/award | Common Stock | 54,000 | — | — | 87,582 |
| 2024-08-12 | Conversion of derivative | Series B-2 Preferred Stock | 40 | $1.0K | $40.0K | 0 |
Key Dates
| Date | Description |
|---|---|
| 2024-08-12 | Conversion of derivative (772 shares) |
| 2026-09-24 | Grant/award (54,000 shares) |
| 2024-08-12 | Conversion of derivative (40 shares) |
Keywords
insider transaction, Form 4, DRIO, DarioHealth Corp., neutral, Yoav Shaked
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.